Примери за използване на Choline chloride на Английски и техните преводи на Български
{-}
-
Colloquial
-
Official
-
Medicine
-
Ecclesiastic
-
Ecclesiastic
-
Computer
Choline chloride(China).
Latex 97 Choline chloride.
BASF claims that it produced additional documents concerning choline chloride.
Hot Tags: high grade amino acid choline chloride 99%, China factory supplier, high quality, high purity, best selling, excellent price.
In this case, the business activities relating to choline chloride were conducted by Akzo Nobel Chemicals, Akzo Nobel Functional Chemicals and Akzo Nobel Chemicals SpA.
In any event,it was the meeting of 17 May 1999 that prompted the Commission to request information on choline chloride.
The Commission states that the product concerned, choline chloride, is a member of the B-complex group of water-soluble vitamins(vitamin B4).
That is so here, however, since dyestuffs(to which Decision 69/243 relates),PVC(to which Decision 94/559 relates) and choline chloride belong to entirely different markets.
Turnover in the choline chloride sector appears in the accounts of Akzo Nobel Chemicals, Akzo Nobel Functional Chemicals and Akzo Nobel Chemicals SpA.
By Decision 2005/566/EC of 9 December 2004 relating to a proceeding under Article 81[EC] andArticle 53 of the EEA Agreement(Case COMP/E-2/37.533- Choline chloride) summary published in OJ 2005 L 190, p.
Now we can supply Choline Chloride over 20000 MT, Yeast Powder 5000MT, Allicin 5000MT, Betaine 3000MT, Bacillus subtilis, Photosynthetic Bacteria 2000MT yearly and so on.
BASF AND UCB v COMMISSION the products and undertakings involved, the duration, the imminent conclusion of a judicial settlement with theUnited States Department of Justice concerning, inter alia, choline chloride.
It follows from recital 40 to the Decision that in 1990 imports of choline chloride represented almost 9% of the value of the Community market(3 525 tonnes imported out of 40 000 tonnes).
BASF AND UCB v COMMISSION participating in a complex of agreements and concerted practices consisting of price fixing, market sharing andagreed actions against competitors in the choline chloride sector in the EEA(Article 1 of the Decision).
As for the fact that there were collusive arrangements concerning choline chloride, it is sufficient to observe that the Commission was aware of those arrangements well before the meeting in question as a result of Chinook's communication(see paragraph 3 above).
If the producers had decided to sell to converters and to European distributors at prices that were too low(because of excess capacity), that,according to recital 151 to the Decision, would have allowed those converters and distributors to export choline chloride to the United States at competitive prices.
(Competition- Cartels in the vitamin products sector- Choline chloride(Vitamin B4)- Decision finding an infringement of Article 81 EC and Article 53 of the Agreement on the European Economic Area- Attributability of the infringement).
Commission stated at recital 199 to the Decision that it would take into account the relatively low value of the choline chloride market in the EEA(EUR 52.6 million in 1997, the last full year of the infringement).
In part G, which covers choline chloride and consists of 3 pages, BASF refers to four meetings of the global choline chloride cartel held between spring 1992 and November 1992, including the Ludwigshafen meeting, and also to six other meetings culminating in the April 1994 meeting in Johor Bahru.
According to the Scholz statement(point 10),‘[at that meeting, BASF stated that it was]involved in illegal activities relating to choline chloride, including blends and pre-mixes, as the Commission's own account of the meeting makes clear.
It follows from points 168 and 169 of the statement of objections that, according to the Commission's appraisals, the European part of the cartel constituted a particular application of the principles adopted at global level,which was made possible because the North American producers provided an assurance that they would not interfere in the European market by exporting choline chloride to that market.
According to the Commission, the cartel consisted of a continuing agreement between producers of choline chloride, which comprised, in essence, global arrangements and regional‘sub-arrangements' at European level(points 79 and 84 of the statement of objections).
APPLICATION for annulment of Commission Decision 2005/566/EC of 9 December 2004 relating to a proceeding under Article 81[EC] andArticle 53 of the EEA Agreement(Case COMP/E-2/37.533- Choline chloride)(summary published in OJ 2005 L 190, p. 22).
Case T-112/05: Akzo Nobel NV andOthers v Commission of the European Communities(Competition- Cartels in the vitamin products sector- Choline chloride(Vitamin B4)- Decision finding an infringement of Article 81 EC and Article 53 of the Agreement on the European Economic Area- Attributability of the infringement).
The argument that decisions relating to pricing and price increases are in principle taken by the marketing managers for the products concerned, who act within the irrespective subsidiaries, andin particular by the choline chloride marketing manager(see paragraphs 38 and 41 above), cannot refute that conclusion.
In addition, point 168 of the statement of objections refers to a common objective of eliminating competition on the choline chloride market, to the same anticompetitive objective and to a single economic objective, namely the distortion of the normal evolution of prices on the choline chloride market.
(Competition- Agreements, decisions and concerted practices in the vitamin products sector- Choline chloride(vitamin B4)- Decision finding an infringement of Article 81 EC and Article 53 of the Agreement on the European Economic Area- Fines- Deterrence- Repeated infringement- Cooperation during the administrative procedure- Single and continuous infringement).
In this case, the purpose of the prohibition on exports to the European market was to avoid the disruption of that market by sales of choline chloride at artificially low prices leading to the recovery of part of the fixed costs of excess production(recitals 39 and 68 to the Decision).
Akzo Nobel Chemicals SpA, which was an addressee of the statement of objections because it was suspected of having participated in certain activities regarding choline chloride in Spain, was not an addressee of the Decision because the Commission considered that the evidence gathered was insufficient to hold it liable(recital 176 to the Decision).